Rosuvastatin Tablet

Showing all 3 results

  • Rosuvastatin 10mg
    Rostin 10mg Tablet 10*10's

    COMPOSITION:

    Each film coated tablet contains:
    Rosuvastatin calcium equivalent to Rosuvastatin 10mg

    INDICATIONS:

    Hyperlipidemia and Mixed Dyslipidemia
    Rosuvastatin is indicated as adjunctive therapy to diet to reduce elevated Total-C, LDL-C, ApoB, non HDL-C, and triglycerides and to increase HDL-C in adult patients with primary hyperlipidemia or mixed dyslipidemia. Lipid altering agents should be used in addition to a diet restricted in saturated fat and cholesterol when response to diet and non-pharmacological interventions alone has been inadequate.

    Dosage and Administration:

     10mg once daily, increased if necessary after ot less than 4 weeks to 20mg once daily,Increased after further  4 weeks to 40mg only in severs hypercholesterolaemia with high cardiovascular risk and under specialist supervision, patient of angina Max.20mg per day

  • Rosuvastatin 20mg
    Rostin 20mg Tablet 10*10's

    COMPOSITION:

    Each film coated tablet contains:
    Rosuvastatin calcium equivalent to Rosuvastatin 20mg

    INDICATIONS:

    Hyperlipidemia and Mixed Dyslipidemia
    Rosuvastatin is indicated as adjunctive therapy to diet to reduce elevated Total-C, LDL-C, ApoB, non HDL-C, and triglycerides and to increase HDL-C in adult patients with primary hyperlipidemia or mixed dyslipidemia. Lipid altering agents should be used in addition to a diet restricted in saturated fat and cholesterol when response to diet and non-pharmacological interventions alone has been inadequate.

    Dosage and Administration:

     10mg once daily, increased if necessary after ot less than 4 weeks to 20mg once daily,Increased after further  4 weeks to 40mg only in severs hypercholesterolaemia with high cardiovascular risk and under specialist supervision, patient of angina Max.20mg per day

  • Rosuvastatin 5mg
    Rostin 5mg Tablet 10*10's

    COMPOSITION:

    Each film coated tablet contains:
    Rosuvastatin calcium equivalent to Rosuvastatin 5mg

    INDICATIONS:

    Hyperlipidemia and Mixed Dyslipidemia
    Rosuvastatin is indicated as adjunctive therapy to diet to reduce elevated Total-C, LDL-C, ApoB, non HDL-C, and triglycerides and to increase HDL-C in adult patients with primary hyperlipidemia or mixed dyslipidemia. Lipid altering agents should be used in addition to a diet restricted in saturated fat and cholesterol when response to diet and non-pharmacological interventions alone has been inadequate.

    Dosage and Administration:  

    10mg once daily, increased if necessary after ot less than 4 weeks to 20mg once daily,Increased after further  4 weeks to 40mg only in severs hypercholesterolaemia with high cardiovascular risk and under specialist supervision, patient of angina Max.20mg per day